Who
PERCEPTIVE ADVISORS LLC
Director
Company insider
Files Form 4 as: Director, Immatics; 10% owner, Freenome; Director and 10% owner, LeonaBio; Director, Kardigan; Director and 10% owner, MeiraGTx Holdings; Director and 10% owner, Solid Biosciences; Director and 10% owner, Lyra Therapeutics; 10% owner, Acrivon Therapeutics.
In numbers
- Trades disclosed
- 371
- Buys
- 126
- Sells
- 33
- Bought
- $466.6M
- Sold
- $121.7M
- Companies
- 43
- Companies where not an officer
- 43
- First trade
- 4 Jan 2007
- Last trade
- 26 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 27 Aug 2026 | IMTX ImmaticsBiotechnology | SEC FORM 4 Bought | $7.5M863,060 at $8.69 | filing |
| 20 Jul 2026filed 22 Jul 2026 | FRNM FreenomeDiagnostics & Labs | SEC FORM 4 Code A | $55.0M5,500,000 at $10.00 | filing |
| 23 Jun 2026filed 9 Jul 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 17 Jun 2026filed 13 Jul 2026 | KARD KardiganBiotechnology | SEC FORM 4 Code A | —20,706 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IMTX Immaticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IMTX Immaticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 10 Jun 2026filed 11 Jun 2026 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,500 at $0.00 | filing |
| 17 Apr 2026filed 23 Apr 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code A | $5.0M555,555 at $9.00 | filing |
| 9 Apr 2026filed 10 Jul 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 9 Apr 2026filed 10 Jul 2026 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 25 Mar 2026filed 23 Apr 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —400,000 | filing |
| 25 Mar 2026filed 23 Apr 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —300,000 | filing |
| 25 Mar 2026filed 23 Apr 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 | filing |
| 25 Mar 2026filed 23 Apr 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 | filing |
| 9 Mar 2026filed 11 Mar 2026 | SLDB Solid Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | $50.0M8,912,655 at $5.61 | filing |
| 31 Dec 2025filed 2 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code D | $18.2M2,300,000 at $7.91 | filing |
| 23 Dec 2025filed 23 Dec 2025 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | $8.7M1,372,935 at $6.35 | filing |
| 23 Dec 2025filed 23 Dec 2025 | LONA LeonaBiooption or derivative · Biotechnology | SEC FORM 4 Code A | $24.4M3,838,583 at $6.35 | filing |
News
Immatics (NASDAQ:IMTX) & Anixa Biosciences (NASDAQ:ANIX) Financial ComparisonIMTX · dailypolitical.com · 16 Oct 2026Contrasting Kyntra Bio (NASDAQ:KYNB) & Immatics (NASDAQ:IMTX)IMTX · themarketsdaily.com · 16 Oct 2026
0 headlines in the last 90 days name PERCEPTIVE ADVISORS LLC; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.